CRITERIA FOR ASSESSING VACCINE SAFETY AND EFFICACY

Main Article Content

Ibragimova Xanifa Matkarimovna

Abstract

Annotation


This article examines the principal criteria used to assess vaccine safety and efficacy throughout the stages of clinical development and post-marketing surveillance. The study reviews the phased clinical trial framework, the statistical and epidemiological measures used to quantify efficacy, and the pharmacovigilance systems established to monitor adverse events following immunization. The findings highlight that vaccine evaluation is a continuous, multi-stage process extending well beyond initial licensure, integrating randomized controlled trial data with long-term population-level surveillance

Article Details

Section
Articles

References

World Health Organization (WHO). Guidelines on Clinical Evaluation of Vaccines: Regulatory Expectations. – Geneva: WHO, 2017.

World Health Organization (WHO). Global Manual on Surveillance of Adverse Events Following Immunization. – Geneva: WHO, 2014.

Plotkin S.A., Orenstein W.A., Offit P.A., Edwards K.M. Plotkin's Vaccines, 7th Edition. – Philadelphia: Elsevier, 2018.